Evidence map›Paper›PMID 35328335›Full record

ArticleInternational journal of molecular sciences2022

Neuroprotective Effect of Luteolin-7-O-Glucoside against 6-OHDA-Induced Damage in Undifferentiated and RA-Differentiated SH-SY5Y Cells.

Stephanie Cristine Hepp Rehfeldt, Joana Silva, Celso Alves, Susete Pinteus, Rui Pedrosa, Stefan Laufer, Márcia Inês Goettert

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The flavonoid luteolin reduces mutant huntingtin aggregation and cytotoxicity in huntingtin-mutated neuroblastoma cells.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Neurodegenerative Diseases: From Molecular Basis to Therapy.International journal of molecular sciences · 2022
    Article
  20. Pharmaceuticals (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Stephanie Cristine Hepp RehfeldtCell Culture Laboratory, Graduate Program in Biotechnology, University of Vale do Taquari (Univates), Lajeado 95914-014, RS, Brazil.ORCID 0000-0002-0362-3129
Joana SilvaMarine and Environmental Sciences Centre (MARE), Polytechnic of Leiria, 2520-630 Peniche, Portugal.ORCID 0000-0003-1224-1699
Celso AlvesMarine and Environmental Sciences Centre (MARE), Polytechnic of Leiria, 2520-630 Peniche, Portugal.ORCID 0000-0003-1581-2127
Susete PinteusMarine and Environmental Sciences Centre (MARE), Polytechnic of Leiria, 2520-630 Peniche, Portugal.ORCID 0000-0002-3290-3111
Rui PedrosaMARE-Marine and Environmental Sciences Centre, ESTM, Polytechnic of Leiria, 2520-614 Peniche, Portugal.
Stefan LauferDepartment of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Eberhard Karls Universität Tübingen, D 72076 Tubingen, Germany.ORCID 0000-0001-6952-1486
Márcia Inês GoettertCell Culture Laboratory, Graduate Program in Biotechnology, University of Vale do Taquari (Univates), Lajeado 95914-014, RS, Brazil.
Instituto Politécnico de Leiria · PTUnivates · BRBernstein Center for Computational Neuroscience Tübingen · DE

Funding

BioISI-BioSystems and Integrative Sciences Institute UIDP/04046/2020 and UIDB/04046/2020Conselho Nacional de Pesquisa (CNPq) 420381/2018-0Coordenação de Aperfeicoamento de Pessoal de Nível Superior 001Portuguese Foundation for Science and Technology(FCT) UID/04292/2020
6 · The paper itself

Abstract

Luteolin is one of the most common flavonoids present in edible plants and its potential benefits to the central nervous system include decrease of microglia activation, neuronal damage and high antioxidant properties. The aim of this research was to evaluate the neuroprotective, antioxidant and anti-inflammatory activities of luteolin-7-O-glucoside (Lut7). Undifferentiated and retinoic acid (RA)-differentiated SH-SY5Y cells were pretreated with Lut7 and incubated with 6-hydroxydopamine (6-OHDA). Cytotoxic and neuroprotective effects were determined by MTT assay. Antioxidant capacity was determined by DPPH, FRAP, and ORAC assays. ROS production, mitochondrial membrane potential (ΔΨm), Caspase-3 activity, acetylcholinesterase inhibition (AChEI) and nuclear damage were also determined in SH-SY5Y cells. TNF-α, IL-6 and IL-10 release were evaluated in LPS-induced RAW264.7 cells by ELISA. In undifferentiated SH-SY5Y cells, Lut7 increased cell viability after 24 h, while in RA-differentiated SH-SY5Y cells, Lut7 increased cell viability after 24 and 48 h. Lut7 showed a high antioxidant activity when compared with synthetic antioxidants. In undifferentiated cells, Lut7 prevented mitochondrial membrane depolarization induced by 6-OHDA treatment, decreased Caspase-3 and AChE activity, and inhibited nuclear condensation and fragmentation. In LPS-stimulated RAW264.7 cells, Lut7 treatment reduced TNF-α levels and increased IL-10 levels after 3 and 24 h, respectively. In summary, the results suggest that Lut7 has neuroprotective effects, thus, further studies should be considered to validate its pharmacological potential in more complex models, aiming the treatment of neurodegenerative diseases.

Indexed as

NeuroblastomaNeuroprotective AgentsAcetylcholinesteraseAntioxidantsApoptosisCaspase 3Cell Line, TumorCell SurvivalFlavonesGlucosidesHumansInterleukin-10LipopolysaccharidesLuteolinMembrane Potential, MitochondrialOxidopamineAcetylcholinesteraseAntioxidantsCaspase 3FlavonesGlucosidesInterleukin-10LipopolysaccharidesLuteolinluteolin-7-glucosideNeuroprotective AgentsOxidopamineTretinoinTumor Necrosis Factor-alpha6-hydroxydopamineapoptosisbiological productscell culture techniquesmitochondrial membrane potentialneurodegenerative diseasesneurodegenerative disordersneuroprotective effectoxidative stress

Identifiers

PMID35328335
PMCPMC8949357
OpenAlexW4220677119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.